Double-blind randomized trial of nicotinamide on early-onset diabetes.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 1531328.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine the efficacy of nicotinamide in inducing remission in early-onset insulin-dependent diabetes mellitus. This study was a double-blind, randomized clinical trial. Nicotinamide failed to induce remission or differences on beta-cell secretion between the two groups.
Medical subject headings
- Diabetes Mellitus, Type 1
- Niacinamide